Skip to content
PubMed This is a summary of 64 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 64 referenced papers

Top Authors

José G. Montoya
Medical Research Foundation
Ildikò Rita Dunay
Otto-von-Guericke-Universität Magdeburg
Ross F. Waller
University of Cambridge
L. David Sibley
Washington University in St. Louis
J. P. Dubey
Beltsville Agricultural Research Center
Konstantin Barylyuk
University of Cambridge
Xing‐Quan Zhu
Shanxi Agricultural University
Masahiro Yamamoto
The University of Osaka
Kathryn S. Lilley
University of Cambridge

Top Institutions

Ranked by publications Top 10 institutions

References

References (64)
  1. 1

    Mesial Temporal Lobe Epilepsy in Congenital Toxoplasmosis: A Case Report.

    Jeong WK, Joo BE, Seo JH, et al.

    Journal of epilepsy research 2015; (5(1)):25-8 doi:10.14581/jer.15007.

    PMID: 26157672
  2. 2

    Patterns of Hydrocephalus Caused by Congenital Toxoplasma gondii Infection Associate With Parasite Genetics.

    Hutson SL, Wheeler KM, McLone D, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015; (61(12)):1831-4 doi:10.1093/cid/civ720.

    PMID: 26405147
  3. 3

    Congenital Toxoplasmosis: A Review.

    Hampton MM

    Neonatal network : NN 2015; (34(5)):274-8 doi:10.1891/0730-0832.34.5.274.

    PMID: 26802827
  4. 4

    Prognosis of Fetal Parenchymal Cerebral Lesions without Ventriculomegaly in Congenital Toxoplasmosis Infection.

    Dhombres F, Friszer S, Maurice P, et al.

    Fetal diagnosis and therapy 2017; (41(1)):8-14 doi:10.1159/000445113.

    PMID: 27093552
  5. 5

    Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review.

    Rico-Torres CP, Vargas-Villavicencio JA, Correa D

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2016; (35(7)):1079-88 doi:10.1007/s10096-016-2656-2.

    PMID: 27146878
  6. 6

    Frequency of anti- Toxoplasma gondii IgA, IgM, and IgG antibodies in high-risk pregnancies, in Brazil.

    Murata FH, Ferreira MN, Camargo NS, et al.

    Revista da Sociedade Brasileira de Medicina Tropical 2016; (49(4)):512-4.

    PMID: 27598642
  7. 7

    Congenital toxoplasmosis: Clinical features, outcomes, treatment, and prevention.

    Singh S

    Tropical parasitology 2016; (6(2)):113-122 doi:10.4103/2229-5070.190813.

    PMID: 27722099
  8. 8

    Late diagnosis of congenital toxoplasmosis based on serological follow-up: A case report.

    Dard C, Chemla C, Fricker-Hidalgo H, et al.

    Parasitology international 2017; (66(2)):186-189 doi:10.1016/j.parint.2016.12.004.

    PMID: 27956093
  9. 9

    High Frequency of Bone Marrow Depression During Congenital Toxoplasmosis Therapy in a Cohort of Children Identified by Neonatal Screening in Minas Gerais, Brazil.

    Carellos EVM, de Andrade JQ, Romanelli RMC, et al.

    The Pediatric infectious disease journal 2017; (36(12)):1169-1176 doi:10.1097/INF.0000000000001561.

    PMID: 28151845
  10. 10

    Management of suspected primary Toxoplasma gondii infection in pregnant women in Norway: twenty years of experience of amniocentesis in a low-prevalence population.

    Findal G, Helbig A, Haugen G, et al.

    BMC pregnancy and childbirth 2017; (17(1)):127 doi:10.1186/s12884-017-1300-1.

    PMID: 28441952
  11. 11

    [Effect of antenatal spiramycin treatment on the frequency of retinochoroiditis due to congenital toxoplasmosis in a Colombian cohort].

    Zuluaga LM, Hernández JC, Castaño CF, Donado JH

    Biomedica : revista del Instituto Nacional de Salud 2017; (37(0)):86-91 doi:10.7705/biomedica.v37i2.2818.

    PMID: 28527270
  12. 12

    IgG Avidity Test in Congenital Toxoplasmosis Diagnoses in Newborns.

    Fonseca ZC, Rodrigues IMX, Melo NCE, et al.

    Pathogens (Basel, Switzerland) 2017; (6(2)) doi:10.3390/pathogens6020026.

    PMID: 28629167
  13. 13

    Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review.

    Ben-Harari RR, Goodwin E, Casoy J

    Drugs in R&D 2017; (17(4)):523-544 doi:10.1007/s40268-017-0206-8.

    PMID: 28879584
  14. 14

    First report of Toxoplasma gondii sporulated oocysts and Giardia duodenalis in commercial green-lipped mussels (Perna canaliculus) in New Zealand.

    Coupe A, Howe L, Burrows E, et al.

    Parasitology research 2018; (117(5)):1453-1463 doi:10.1007/s00436-018-5832-8.

    PMID: 29550995
  15. 15

    Perinatal Care of Infants with Congenital Birth Defects.

    Sewell EK, Keene S

    Clinics in perinatology 2018; (45(2)):213-230 doi:10.1016/j.clp.2018.01.007.

    PMID: 29747884
  16. 16

    Hearing Disorders in Congenital Toxoplasmosis: A Literature Review.

    Corrêa CC, Maximino LP, Weber SAT

    International archives of otorhinolaryngology 2018; (22(3)):330-333 doi:10.1055/s-0037-1605377.

    PMID: 29983776
  17. 17

    Congenital toxoplasmosis: An overview of the neurological and ocular manifestations.

    Khan K, Khan W

    Parasitology international 2018; (67(6)):715-721 doi:10.1016/j.parint.2018.07.004.

    PMID: 30041005
  18. 18

    Adverse Reactions in Antifolate-Treated Toxoplasmic Retinochoroiditis.

    Borkowski PK, Brydak-Godowska J, Basiak W, et al.

    Advances in experimental medicine and biology 2018; (1108()):37-48 doi:10.1007/5584_2018_262.

    PMID: 30191431
  19. 19

    Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.

    Dunay IR, Gajurel K, Dhakal R, et al.

    Clinical microbiology reviews 2018; (31(4)) doi:10.1128/CMR.00057-17.

    PMID: 30209035
  20. 20

    Role of Toxoplasma IgA as Part of a Reference Panel for the Diagnosis of Acute Toxoplasmosis during Pregnancy.

    Olariu TR, Blackburn BG, Press C, et al.

    Journal of clinical microbiology 2019; (57(2)) doi:10.1128/JCM.01357-18.

    PMID: 30463899
  21. 21

    Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group.

    Peyron F, L'ollivier C, Mandelbrot L, et al.

    Pathogens (Basel, Switzerland) 2019; (8(1)) doi:10.3390/pathogens8010024.

    PMID: 30781652
  22. 22

    Is having any prenatal care associated with lower infant mortality in West Africa? Evidence from the Demographic and Health Surveys.

    Taylor YJ, Laditka JN, Laditka SB, et al.

    Health care for women international 2019; (40(2)):196-212 doi:10.1080/07399332.2018.1522317.

    PMID: 30849281
  23. 23

    Outcomes of hydrocephalus secondary to congenital toxoplasmosis.

    McLone D, Frim D, Penn R, et al.

    Journal of neurosurgery. Pediatrics 2019; (24(5)):601-608 doi:10.3171/2019.6.PEDS18684.

    PMID: 31491752
  24. 24

    Innate, adaptive, and cell-autonomous immunity against Toxoplasma gondii infection.

    Sasai M, Yamamoto M

    Experimental & molecular medicine 2019; (51(12)):1-10 doi:10.1038/s12276-019-0353-9.

    PMID: 31827072
  25. 25

    Toxoplasma gondii tkl1 Deletion Mutant Is a Promising Vaccine against Acute, Chronic, and Congenital Toxoplasmosis in Mice.

    Wang JL, Liang QL, Li TT, et al.

    Journal of immunology (Baltimore, Md. : 1950) 2020; (204(6)):1562-1570 doi:10.4049/jimmunol.1900410.

    PMID: 31996457
  26. 26

    A Proinflammatory Immune Response Might Determine Toxoplasma gondii Vertical Transmission and Severity of Clinical Features in Congenitally Infected Newborns.

    Gómez-Chávez F, Cañedo-Solares I, Ortiz-Alegría LB, et al.

    Frontiers in immunology 2020; (11()):390 doi:10.3389/fimmu.2020.00390.

    PMID: 32231666
  27. 27

    Toxoplasma gondii-specific IgG avidity testing in pregnant women.

    Garnaud C, Fricker-Hidalgo H, Evengård B, et al.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2020; (26(9)):1155-1160 doi:10.1016/j.cmi.2020.04.014.

    PMID: 32334096
  28. 28

    Seronegative ocular toxoplasma panuveitis in an immunocompetent patient.

    Sigle M, El Atrouni W, Ajlan RS

    American journal of ophthalmology case reports 2020; (19()):100745 doi:10.1016/j.ajoc.2020.100745.

    PMID: 32566798
  29. 29

    Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder.

    Frye RE, Rossignol DA, Scahill L, et al.

    Seminars in pediatric neurology 2020; (35()):100835 doi:10.1016/j.spen.2020.100835.

    PMID: 32892962
  30. 30

    Treatment of Acute Toxoplasmosis in Pregnancy: Influence in the Mother-to-Child Transmission.

    Bartholo BBGR, Monteiro DLM, Rodrigues NCP, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2020; (42(12)):1505-1510 doi:10.1016/j.jogc.2020.04.021.

    PMID: 32912728
  31. 31

    A Comprehensive Subcellular Atlas of the Toxoplasma Proteome via hyperLOPIT Provides Spatial Context for Protein Functions.

    Barylyuk K, Koreny L, Ke H, et al.

    Cell host & microbe 2020; (28(5)):752-766.e9 doi:10.1016/j.chom.2020.09.011.

    PMID: 33053376
  32. 32

    Ocular Outcome of Brazilian Patients With Congenital Toxoplasmosis.

    Lago EG, Endres MM, Scheeren MFDC, Fiori HH

    The Pediatric infectious disease journal 2021; (40(1)):e21-e27 doi:10.1097/INF.0000000000002931.

    PMID: 33060522
  33. 33

    All about Toxoplasma gondii infections in pigs: 2009-2020.

    Dubey JP, Cerqueira-Cézar CK, Murata FHA, et al.

    Veterinary parasitology 2020; (288()):109185 doi:10.1016/j.vetpar.2020.109185.

    PMID: 33271424
  34. 34

    [Toxoplasmosis in pregnancy: Practical Management].

    Mandelbrot L, Kieffer F, Wallon M, et al.

    Gynecologie, obstetrique, fertilite & senologie 2021; (49(10)):782-791 doi:10.1016/j.gofs.2021.03.003.

    PMID: 33677120
  35. 35

    Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak.

    Conceição AR, Belucik DN, Missio L, et al.

    Ophthalmology 2021; (128(9)):1346-1355 doi:10.1016/j.ophtha.2021.03.009.

    PMID: 33711379
  36. 36

    One severe case of congenital toxoplasmosis in China with good response to azithromycin.

    Li J, Zhao J, Yang X, et al.

    BMC infectious diseases 2021; (21(1)):920 doi:10.1186/s12879-021-06619-1.

    PMID: 34488656
  37. 37

    A fresh look at the role of spiramycin in preventing a neglected disease: meta-analyses of observational studies.

    Montoya JG, Laessig K, Fazeli MS, et al.

    European journal of medical research 2021; (26(1)):143 doi:10.1186/s40001-021-00606-7.

    PMID: 34895348
  38. 38

    Congenital Toxoplasmosis: The State of the Art.

    Bollani L, Auriti C, Achille C, et al.

    Frontiers in pediatrics 2022; (10()):894573 doi:10.3389/fped.2022.894573.

    PMID: 35874584
  39. 39

    Anti-Toxoplasma Effects of Dracocephalum Polychaetum Essential Oil.

    Khamesipour F, Pourmohammad A, Jafarian-Dehkordi M

    Interdisciplinary perspectives on infectious diseases 2022; (2022()):6091834 doi:10.1155/2022/6091834.

    PMID: 35879954
  40. 40

    Anti-Toxoplasma gondii IgM Long Persistence: What Are the Underlying Mechanisms?

    Vargas-Villavicencio JA, Cañedo-Solares I, Correa D

    Microorganisms 2022; (10(8)) doi:10.3390/microorganisms10081659.

    PMID: 36014077
  41. 41

    [Ocular toxoplasmosis in infants 0 to 12 months of age with congenital toxoplasmosis].

    González V L, Cardozo S O, Samudio A M, Mesquita R M

    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 2022; (39(3)):265-272 doi:10.4067/s0716-10182022000200265.

    PMID: 36156688
  42. 42

    Asymmetric eye size in an infant.

    Edwards BD, Vayalumkal JV, Chawla R, et al.

    Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada 2020; (5(3)):187-192 doi:10.3138/jammi-2020-0006.

    PMID: 36341312
  43. 43

    Congenital toxoplasmosis with severe neurological disease in a referral hospital in Peru.

    Maquera-Afaray J, Luna-Vilchez M, Salazar-Mesones B, et al.

    Revista peruana de medicina experimental y salud publica 2022; (39(2)):208-213 doi:10.17843/rpmesp.2022.392.10897.

    PMID: 36477322
  44. 44

    Toxoplasmosis Infection during Pregnancy.

    Deganich M, Boudreaux C, Benmerzouga I

    Tropical medicine and infectious disease 2022; (8(1)) doi:10.3390/tropicalmed8010003.

    PMID: 36668910
  45. 45

    Toxoplasmosis: A Timeless Challenge for Pregnancy.

    Damar Çakırca T, Can İN, Deniz M, et al.

    Tropical medicine and infectious disease 2023; (8(1)) doi:10.3390/tropicalmed8010063.

    PMID: 36668970
  46. 46

    Evaluation of the impact of the first evidence-based guidelines for congenital toxoplasmosis in Armenia (Quindío) Colombia: An observational retrospective analysis.

    Mejia-Oquendo M, Marulanda-Ibarra E, Gomez-Marin JE

    Lancet regional health. Americas 2021; (1()):100010 doi:10.1016/j.lana.2021.100010.

    PMID: 36776756
  47. 47

    Evaluation of Toxoplasma gondii IgG avidity assays through a comparison of IgM serostatus.

    Ikuta K, Kanno R, Bessho T, et al.

    Diagnostic microbiology and infectious disease 2023; (105(4)):115901 doi:10.1016/j.diagmicrobio.2023.115901.

    PMID: 36889215
  48. 48

    Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: A systematic review and meta-analysis.

    Cifuentes-González C, Rojas-Carabali W, Pérez ÁO, et al.

    PloS one 2023; (18(4)):e0283845 doi:10.1371/journal.pone.0283845.

    PMID: 37011101
  49. 49

    Comparison of adverse reactions of spiramycin versus pyrimethamine/sulfadiazine treatment of toxoplasmosis in pregnancy: is spiramycin really the drug of choice for unproven infection of the fetus?

    Prasil P, Sleha R, Kacerovsky M, Bostik P

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2023; (36(1)):2215377 doi:10.1080/14767058.2023.2215377.

    PMID: 37217458
  50. 50

    Prevalence of Toxoplasma gondii in Galapagos birds: Inference of risk factors associated with diet.

    Mosquera JD, Valle CA, Nieto-Claudin A, et al.

    PloS one 2023; (18(7)):e0287403 doi:10.1371/journal.pone.0287403.

    PMID: 37405972
  51. 51

    Diagnosis of Congenital Toxoplasmosis: Challenges and Management Outcomes.

    Losa A, Carvalho I, Sousa B, et al.

    Cureus 2024; (16(1)):e52971 doi:10.7759/cureus.52971.

    PMID: 38406029
  52. 52

    Employing digital PCR for enhanced detection of perinatal Toxoplasma gondii infection: A cross-sectional surveillance and maternal-infant outcomes study in El Salvador.

    Lynn MK, Rodriguez Aquino MS, Cornejo Rivas PM, et al.

    PLoS neglected tropical diseases 2024; (18(5)):e0012153 doi:10.1371/journal.pntd.0012153.

    PMID: 38768194
  53. 53

    The prevention of congenital toxoplasmosis using a combination of Spiramycin and Cotrimoxazole: The long-time experience of a tertiary referral centre.

    De Santis M, Tartaglia S, Apicella M, et al.

    Tropical medicine & international health : TM & IH 2024; (29(8)):697-705 doi:10.1111/tmi.14021.

    PMID: 38842439
  54. 54

    Navigating methotrexate toxicity: Examining the therapeutic roles of folinic acid and glucarpidase.

    Chan BS, Bosco AA, Buckley NA

    British journal of clinical pharmacology 2025; (91(3)):628-635 doi:10.1111/bcp.16096.

    PMID: 38889902
  55. 55

    Mammalian placental explants: A tool for studying host-parasite interactions and placental biology.

    Castillo C, Díaz-Luján C, Liempi A, et al.

    Placenta 2025; (166()):62-70 doi:10.1016/j.placenta.2024.06.016.

    PMID: 38910051
  56. 56

    Toxoplasma gondii genotypes and frequency in domestic cats from Romania.

    Györke A, Balea A, Borșan S, et al.

    BMC veterinary research 2024; (20(1)):369 doi:10.1186/s12917-024-04210-9.

    PMID: 39152437
  57. 57

    Associations between Fetal Symptoms during Pregnancy and Neonatal Clinical Complications with Toxoplasmosis.

    Tűzkő N, Bartek V, Simonyi A, et al.

    Children (Basel, Switzerland) 2024; (11(9)) doi:10.3390/children11091111.

    PMID: 39334643
  58. 58

    Microcephaly Resulting From Congenital Toxoplasmosis: What the Radiologist can Expect to See? A Case Report.

    Salma M, Soumia EG, Ihssan HH, et al.

    Radiology case reports 2024; (19(12)):6657-6661 doi:10.1016/j.radcr.2024.09.079.

    PMID: 39430228
  59. 59

    Efficacy of amniotic fluid, blood and urine samples for the diagnosis of toxoplasmosis in pregnant women candidates for amniocentesis using serological and molecular techniques.

    Abedian R, Esboei BR, Kordi S, et al.

    BMC pregnancy and childbirth 2024; (24(1)):771 doi:10.1186/s12884-024-06979-x.

    PMID: 39578753
  60. 60

    The effectiveness of congenital toxoplasmosis treatment in minimizing hearing loss: A systematic review.

    Silva Santos RM, Liboredo R, da Silva AS, et al.

    Science progress 2025; (108(2)):368504251320834 doi:10.1177/00368504251320834.

    PMID: 40443220
  61. 61

    Congenital toxoplasmosis: an observational retrospective study in the Eastern Sicily.

    Garozzo MT, Garozzo R, Betta P, et al.

    Frontiers in pediatrics 2025; (13()):1597001 doi:10.3389/fped.2025.1597001.

    PMID: 40656197
  62. 62

    Congenital toxoplasmosis.

    Cerisola A, Francia M, Gesuele JP

    Seminars in pediatric neurology 2025; (54()):101203 doi:10.1016/j.spen.2025.101203.

    PMID: 40701684
  63. 63

    Function and mechanism of dopamine receptor D2 (DRD2) in neuroinflammation and behavioral disorders in C57BL/6J mice infected with Toxoplasma gondii TgCtWh6 strain.

    Sun H, Xie X, Li Y, et al.

    Brain, behavior, and immunity 2026; (131()):106136 doi:10.1016/j.bbi.2025.106136.

    PMID: 41106615
  64. 64

    IgG avidity and placenta real-time PCR in detection of active maternal toxoplasmosis: relation to pregnancy outcomes.

    Allam AF, Shehab AY, Ahmed NA, et al.

    Experimental parasitology 2025; (279()):109065 doi:10.1016/j.exppara.2025.109065.

    PMID: 41260562